Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

Clinical trial NCT04394689 · COMPLETED

Trial details

NCT number: NCT04394689
Sponsor: Micron Biomedical, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Measles Rubella Vaccination Healthy

Start date: 2021-05-19
Primary completion: 2022-11-23
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.